ancrod
Sign in to saveAncrod (current brand name: Viprinex) is a defibrinogenating agent derived from the venom of the Malayan pit viper. Defibrinogenating blood produces an anticoagulant effect. Ancrod is not approved or marketed in any country. It is a thrombin-like serine protease.
Research
511 papers- Experimental ancrod (Arvin) for acute ischemic stroke: nursing implications.The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses · 1991
- Ancrod.Current medical research and opinion · 2002
- Ancrod in the treatment of acute ischaemic stroke.Drugs · 1997
- Ancrod in glomerulonephritis.The Quarterly journal of medicine · 1988
- Ancrod: understanding the agent.Seminars in vascular surgery · 1996
via PubMed
~9 min read
Encyclopedic overview
12 sectionsContents
- Medical use
- Pregnancy
- Contraindications and precautions
- Side effects
- Pharmacology
- Chemistry
- History
- Society and culture
- Research
- References
- See also
- External links
Ancrod (current brand name: Viprinex) is a defibrinogenating agent derived from the venom of the Malayan pit viper. Defibrinogenating blood produces an anticoagulant effect. Ancrod is not approved or marketed in any country. It is a thrombin-like serine protease.
==Medical use== As of 2017 ancrod was not marketed for any medical use.
Excerpted from Wikipedia’s “ancrod” article, available under the CC BY-SA 4.0 licence.